伊诺根获得FDA批准,其SIMEOX 200装置可帮助肺部疾病患者的粘液清除. Inogen gains FDA approval for its SIMEOX 200 device to aid mucus clearance in lung disease patients.

医疗科技公司Inogen已经获得FDA批准, Inogen, a medical tech company, has received FDA approval for its SIMEOX 200 device, designed to help patients with chronic lung diseases like COPD and cystic fibrosis. 该装置使用振动和压力变化来清除肺部的粘液。 The device uses vibrations and pressure changes to clear mucus from the lungs. Inogen 计划明年在目标地点推出该设备。 Inogen plans to launch the device in targeted locations next year.